Edap TMS (FRA:EDA) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EDA Edap TMS SA FRA:EDA
59 GF Score
Price €4.82
GF Value €3.60
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Edap TMS FFO per Share?

FFO per Share only applies to REITs.

FRA:EDA
59GF Score
Edap TMS SA FRA:EDA
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Edap TMS (FRA:EDA) Overvalued in 2026?

Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued. The current stock price of €4.82 is trading 33.9% above its estimated GF Value™ of €3.60. GuruFocus considers Edap TMS to be Significantly Overvalued.

Key valuation signals for FRA:EDA:

  • FFO per Share:
  • GF Value™: €3.60 vs. price of €4.82 (33.9% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the FRA:EDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edap TMS Business Description

Other Exchanges FOCL:USAEDA:Germany
Address Parc d\'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
59GF Score

Get the complete analysis for FRA:EDA

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.82
Price
€3.60
GF Value